Drug:
Reaction: CONDITION AGGRAVATED
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26555557 |
US |
63 | 2 |
Stress cardiomyopathy, Rash pruritic, Urticaria, Condition aggravated, |
||||
NIVOLUMAB, ALPRAZOLAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SACUBITRIL AND VALSARTAN, NITROGLYCERIN, PANTOPRAZOLE, CLOPIDOGREL, PREDNISONE, MONTELUKAST SODIUM, |
||||
| 2 | 26555562 |
EU |
||
Angioedema, Ocular hypertension, Chronic spontaneous urticaria, Condition aggravated, Urticaria, Osteoporosis, Asthenia, Myalgia, Drug intolerance, Off label use, |
||||
OMALIZUMAB, CYCLOSPORINE, |
||||
| 3 | 26555622 |
JP |
36 | 1 |
Condition aggravated, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, PIOGLITAZONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 4 | 26555647 |
US |
2 | |
Scoliosis, Freezing phenomenon, Condition aggravated, Fall, Dementia with Lewy bodies, |
||||
| 5 | 26555666 |
US |
1 | |
Drug ineffective, Condition aggravated, Inflammation, |
||||
INFLIXIMAB, |
||||
| 6 | 26555720 |
33 | ||
Hidradenitis, Condition aggravated, |
||||
BIMEKIZUMAB, |
||||
| 7 | 26555955 |
56 | ||
Hidradenitis, Condition aggravated, Sensitivity to weather change, |
||||
BIMEKIZUMAB, |
||||
| 8 | 26556027 |
EU |
51 | 1 |
Drug withdrawal syndrome, Restless legs syndrome, Condition aggravated, Product use in unapproved indication, Akathisia, Nausea, Depression, Neuralgia, Suicidal ideation, Anxiety, Dysphoria, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, PRAMIPEXOLE, BISOPROLOL FUMARATE, |
||||
| 9 | 26556061 |
US |
1 | |
Condition aggravated, |
||||
APREMILAST, |
||||
| 10 | 26556099 |
US |
26 | |
Haemorrhage, Condition aggravated, Therapy interrupted, |
||||
INFLIXIMAB-DYYB, |
||||
| 11 | 26556112 |
EU |
59 | 2 |
Subretinal fluid, Detachment of macular retinal pigment epithelium, Retinal haemorrhage, Therapeutic product effect decreased, Condition aggravated, Off label use, |
||||
RANIBIZUMAB, BEVACIZUMAB, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, |
||||
| 12 | 26556380 |
EU |
||
Hypertension, Condition aggravated, Intentional product use issue, |
||||
BEVACIZUMAB, ATEZOLIZUMAB, |
||||
| 13 | 26556433 |
CA |
69 | |
Aphthous ulcer, Stomatitis, Glossitis, Tongue erythema, Tongue disorder, Condition aggravated, Tongue fungal infection, Interstitial lung disease, Arthralgia, Inappropriate schedule of product administration, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, FUROSEMIDE, RABEPRAZOLE, RAMIPRIL, ROSUVASTATIN, LEVOTHYROXINE SODIUM, |
||||
| 14 | 26556486 |
CA |
40 | 2 |
Abdominal distension, Adverse reaction, Back injury, Bursitis, Coeliac disease, Condition aggravated, Dyspepsia, Fall, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, Grip strength decreased, Headache, Hepatitis, Hypoaesthesia, Injury, Insomnia, Intentional product use issue, Liver function test increased, Malaise, Mobility decreased, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Neck pain, Off label use, Pain in extremity, Pneumonia, Product label confusion, Weight increased, Wheezing, Wound infection, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 15 | 26556487 |
US |
59 | 2 |
Condition aggravated, Pruritus, Arthralgia, Myalgia, Ulcer, |
||||
DASATINIB, |
||||
| 16 | 26556507 |
EU |
88 | 2 |
Cardiac failure acute, Gastric cancer, Fluid intake reduced, Condition aggravated, Tachycardia, Muscular weakness, Nasopharyngitis, Obsessive-compulsive disorder, Mobility decreased, Vitamin B12 decreased, Chronic gastritis, Fatigue, |
||||
DICLOFENAC EPOLAMINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, AMLODIPINE BESYLATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 17 | 26556541 |
CA |
45 | |
Condition aggravated, Vomiting, Fistula, Platelet count decreased, White blood cell count increased, Fatigue, Clostridium difficile infection, COVID-19, Nausea, Hypertension, Arthralgia, Paraesthesia, Complication associated with device, Therapeutic response shortened, Off label use, Off label use, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METRONIDAZOLE, METRONIDAZOLE, METRONIDAZOLE, FOLIC ACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 18 | 26556638 |
EU |
88 | 2 |
Gastric cancer, Cardiac failure acute, Obsessive-compulsive disorder, Fluid intake reduced, Vitamin B12 decreased, Condition aggravated, Muscular weakness, Mobility decreased, Nasopharyngitis, Tachycardia, Fatigue, Chronic gastritis, |
||||
DICLOFENAC, DICLOFENAC SODIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 19 | 26556646 |
US |
||
Psoriasis, Condition aggravated, Arthralgia, Arthritis, Product dose omission issue, Alopecia, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 20 | 26556768 |
CA |
77 | 1 |
Cataract, Dyspnoea, Cough, Sputum discoloured, Condition aggravated, Cardiac disorder, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, PREDNISONE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, PREDNISONE, |
||||
| 21 | 26556798 |
US |
||
Condition aggravated, |
||||
ACETAMINOPHEN, |
||||
| 22 | 26556832 |
37 | 2 | |
Condition aggravated, Coagulopathy, Maternal exposure during pregnancy, Off label use, |
||||
URSODIOL, URSOSIOL, |
||||
| 23 | 26556836 |
40 | 1 | |
Condition aggravated, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, |
||||
| 24 | 26556838 |
5 | 2 | |
Condition aggravated, |
||||
LORATADINE, LORATADINE ORAL, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, SULFASALAZINE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 25 | 26556842 |
28 | 2 | |
Condition aggravated, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 26 | 26556864 |
JP |
1 | |
Cardiac failure acute, Condition aggravated, |
||||
| 27 | 26556896 |
IN |
||
Intentional overdose, Compartment syndrome, Reperfusion injury, Dyspnoea, Peripheral ischaemia, Haemodynamic instability, Condition aggravated, |
||||
AMLODIPINE, |
||||
| 28 | 26556898 |
IN |
||
Intentional overdose, Peripheral artery thrombosis, Tachycardia, Hypotension, Hypoxia, Haemodynamic instability, Condition aggravated, |
||||
AMLODIPINE, |
||||
| 29 | 26557105 |
US |
11 | 1 |
Suicidal ideation, Mood swings, Hunger, Thirst, Pollakiuria, Anxiety, Condition aggravated, Nausea, Vomiting, Diarrhoea, Headache, Malaise, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CETIRIZINE HYDROCHLORIDE, |
||||
| 30 | 26557110 |
AE |
44 | 1 |
Drug interaction, Condition aggravated, Therapy non-responder, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, OLANZAPINE, |
||||
| 31 | 26557162 |
US |
2 | |
Condition aggravated, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 32 | 26557421 |
US |
69 | 1 |
Rash macular, Pruritus, Skin burning sensation, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 33 | 26557483 |
US |
67 | 2 |
Tooth extraction, Psoriasis, Condition aggravated, |
||||
RISANKIZUMAB-RZAA, |
||||
| 34 | 26557499 |
5 | 2 | |
Condition aggravated, Off label use, |
||||
LORATADINE, LORATADINE ORAL, ALBUTEROL SULFATE, ALBUTEROL, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, SULFASALAZINE, |
||||
| 35 | 26557562 |
US |
60 | 2 |
Rhinorrhoea, Condition aggravated, Nasal congestion, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 36 | 26557603 |
US |
78 | 1 |
Soliloquy, Condition aggravated, Somnolence, |
||||
PIMAVANSERIN TARTRATE, ENTACAPONE, FINASTERIDE, LOSARTAN, MECLIZINE HCL 12.5 MG, MECLIZINE HCL 25 MG, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, ROSUVASTATIN, |
||||
| 37 | 26557626 |
US |
2 | |
Pyrexia, Rhinorrhoea, Condition aggravated, Nasal discharge discolouration, |
||||
DUPILUMAB, |
||||
| 38 | 26557640 |
CA |
52 | 2 |
Blood bilirubin increased, Bronchiectasis, Asthma-chronic obstructive pulmonary disease overlap syndrome, Hepatic enzyme increased, Total lung capacity increased, Schizophrenia, Oedema peripheral, Hypomania, Lung neoplasm malignant, Cardiac murmur, Nasal polyps, Chronic obstructive pulmonary disease, Rhinitis allergic, Cholelithiasis, Nausea, Off label use, Jaundice cholestatic, Sarcoidosis, Wheezing, Gastrooesophageal reflux disease, Hepatotoxicity, Vomiting, Pneumonia, Condition aggravated, Psychotic disorder, |
||||
FLUTICASONE PROPIONATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACLIDINIUM BROMIDE, ACLIDINIUM BROMIDE, ACLIDINIUM BROMIDE, TIPRANAVIR, TIPRANAVIR, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUDESONIDE, CLONAZEPAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, GLYCOPYRROLATE, LOPINAVIR AND RITONAVIR, LOPINAVIR AND RITONAVIR, LOPINAVIR AND RITONAVIR, LOPINAVIR AND RITONAVIR, LOPINAVIR AND RITONAVIR, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, OLANZAPINE, OLANZAPINE, RISPERIDONE, VALPROATE SODIUM, VALPROATE SODIUM, VALPROATE SODIUM, VALPROATE SODIUM, TIOTROPIUM BROMIDE, CARBAMAZEPINE, CARBAMAZEPINE, TIPRANAVIR, IPRATROPIUM BROMIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, MEPOLIZUMAB, MONTELUKAST, MOMETASONE FUROATE, MEPOLIZUMAB, CICLESONIDE, ALBUTEROL SULFATE, ALBUTEROL, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OLANZAPINE, OLANZAPINE PAMOATE, LAMIVUDINE, LAMIVUDINE ORAL, DIPHENHYDRAMINE HYDROCHLORIDE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CALCIUM CARBONATE, ANTACID, CICLESONIDE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, LACTULOSE, ABACAVIR SULFATE, ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, LITHIUM, LITHIUM BROMATUM, SERTRALINE HYDROCHLORIDE, ZINC OXIDE, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 WARM/LIGHT, ZINC OXIDE OINTMENT, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 WARM/TAN, SKIN PROTECTANT, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 NATURAL/MEDIUM, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 COOL/DEEP, MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN, |
||||
| 39 | 26557802 |
US |
70 | 1 |
Dementia, Hallucination, Confusional state, Gait disturbance, Condition aggravated, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 40 | 26557835 |
40 | 1 | |
Condition aggravated, Off label use, |
||||
MYCOPHENOLIC ACID, MYCOPHENILIC ACID, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, RITUXIMAB, RITUXIMAB, |
||||
| 41 | 26557873 |
PK |
22 | 1 |
Condition aggravated, Tumour lysis syndrome, Renal failure, Sepsis, Staphylococcal infection, |
||||
CISPLATIN, ETOPOSIDE, RASBURICASE, |
||||
| 42 | 26557890 |
|||
Diarrhoea, Weight decreased, Axial spondyloarthritis, Condition aggravated, Colonoscopy, |
||||
CERTOLIZUMAB PEGOL, TIZANIDINE HYDROCHLORIDE, BUDESONIDE, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, FAMOTIDINE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BUSPIRONE HYDROCHLORIDE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ABALOPARATIDE, NORTRIPTYLINE HYDROCHLORIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, COLESTIPOL HYDROCHLORIDE, IRON, CYANOCOBALAMIN, GABAPENTIN, |
||||
| 43 | 26557956 |
CN |
60 | 2 |
Facial spasm, Muscular weakness, Condition aggravated, Hypoaesthesia, Neuropathy peripheral, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 44 | 26557983 |
JP |
||
Hospitalisation, Condition aggravated, |
||||
STIRIPENTOL, STIRIPENTOL, |
||||
| 45 | 26557984 |
EU |
5 | 1 |
Epilepsy, Condition aggravated, Underdose, |
||||
POLYETHYLENE GLYCOL, |
||||
| 46 | 26558017 |
57 | ||
Drug reaction with eosinophilia and systemic symptoms, Encephalopathy, Hallucination, Psychotic disorder, Paranoia, Catatonia, Condition aggravated, |
||||
ALLOPURINOL, RISPERIDONE, BROMFENAC, DIFLUPREDNATE OPHTHALMIC, DIFLUPREDNATE, TIMOLOL, |
||||
| 47 | 26558019 |
PK |
34 | 1 |
Neutropenic sepsis, Diarrhoea, Vomiting, Condition aggravated, Multiple organ dysfunction syndrome, Hypotension, |
||||
CISPLATIN, ETOPOSIDE, RASBURICASE, |
||||
| 48 | 26558130 |
CA |
||
Adverse drug reaction, Condition aggravated, Suicidal ideation, Suicide attempt, Therapy non-responder, Drug ineffective, Underdose, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PAROXETINE HYDROCHLORIDE, APIXABAN, APIXABAN, BREXPIPRAZOLE, BUPROPION, BUPROPION, BUPROPION, LEMBOREXANT, ESCITALOPRAM OXALATE, ESCITALOPRAM, FLUOXETINE HYDROCHLORIDE, GABAPENTIN, LEMBOREXANT, LEMBOREXANT, LORAZEPAM, LURASIDONE HYDROCHLORIDE, LURASIDONE HYDROCHLORIDE, MIRTAZAPINE, MIRTAZAPINE, OLANZAPINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE, QUETIAPINE FUMARATE, QUETIAPINE, RISPERIDONE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VORTIOXETINE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, LORAZEPAM, |
||||
| 49 | 26558168 |
US |
60 | 1 |
Condition aggravated, Product prescribing error, |
||||
DUPILUMAB, DUPILUMAB, ATENOLOL, PIOGLITAZONE AND GLIMEPIRIDE, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, |
||||
| 50 | 26558169 |
US |
1 | |
Dermatitis atopic, Condition aggravated, |
||||
DUPILUMAB, |
||||
| 51 | 26558295 |
GB |
1 | |
Petit mal epilepsy, Condition aggravated, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, INFLIXIMAB, |
||||
| 52 | 26558418 |
US |
1 | |
Hallucination, Condition aggravated, Product distribution issue, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 53 | 26558449 |
CA |
25 | |
Condition aggravated, Drug level decreased, Maternal exposure during pregnancy, Therapeutic response shortened, Off label use, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, AZATHIOPRINE, |
||||
| 54 | 26558493 |
US |
1 | |
Condition aggravated, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 55 | 26558633 |
US |
62 | 2 |
Condition aggravated, Hallucinations, mixed, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, GABAPENTIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, GLIPIZIDE, GLIPIZIDE-TABLETS, MONTELUKAST, DULOXETINE HYDROCHLORIDE, DULOXETINE, LITHIUM CARBONATE, OXYBUTYNIN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 56 | 26558746 |
CA |
41 | |
Blood pressure increased, Condition aggravated, Nasal congestion, Erythema, Cough, Hot flush, Gingivitis, Ear infection, Influenza, Headache, Arthralgia, Gastroenteritis, Therapeutic product effect decreased, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LORAZEPAM, OXYBUTYNIN, VALACYCLOVIR HYDROCHLORIDE, LISDEXAMFETAMINE DIMESYLATE, |
||||
| 57 | 26558812 |
CA |
63 | 2 |
Arthralgia, Arthropathy, C-reactive protein abnormal, C-reactive protein increased, Condition aggravated, Contraindicated product administered, Disability, Drug hypersensitivity, Drug ineffective, Drug-induced liver injury, Fall, Fatigue, Femur fracture, Haematocrit decreased, Haemoglobin decreased, Impaired healing, Joint swelling, Multiple fractures, Musculoskeletal pain, Osteoporosis, Pain, Pain in extremity, Peripheral swelling, Rash, Red blood cell count decreased, Red blood cell sedimentation rate abnormal, Rheumatoid arthritis, Synovitis, |
||||
TOCILIZUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, |
||||
| 58 | 26559001 |
CA |
33 | |
Condition aggravated, Malaise, Mouth swelling, Oral pain, Chills, Dizziness, Fatigue, Nasopharyngitis, Nausea, Pyrexia, Tooth abscess, Tooth infection, Underdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, LORAZEPAM, MESALAMINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, PREDNISONE, PREDNISONE, MESALAMINE, |
||||
| 59 | 26559185 |
2 | ||
Polymyositis, Condition aggravated, Uveitis, |
||||
REPOSITORY CORTICOTROPIN, REPOSITORY CORTICOTROPIN, |
||||
| 60 | 26559319 |
US |
||
Condition aggravated, |
||||
ESOMEPRAZOLE MAGNESIUM, |
||||
| 61 | 26559516 |
GB |
40 | 2 |
Depressed level of consciousness, Liver injury, Condition aggravated, Intentional overdose, Encephalopathy, Glossitis, Thrombocytosis, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, CLOBAZAM, CENOBAMATE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 62 | 26559666 |
|||
Condition aggravated, |
||||
C1 ESTERASE INHIBITOR RECOMBINANT, |
||||
| 63 | 26559713 |
|||
Hidradenitis, Condition aggravated, |
||||
BIMEKIZUMAB, |
||||
| 64 | 26559762 |
US |
35 | 2 |
Immunosuppression, Weight decreased, Keratitis, Squamous cell carcinoma of the cervix, Drug ineffective, Oral candidiasis, Hypersomnia, Hypomagnesaemia, Condition aggravated, Sepsis, Acute kidney injury, Clostridium difficile colitis, Neuropathy peripheral, Fatigue, Thrombosis, Neuropathy peripheral, |
||||
PREDNISONE, PEMBROLIZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, BEVACIZUMAB, HYDROXYCHLOROQUINE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, TISOTUMAB VEDOTIN, |
||||
| 65 | 26559941 |
1 | ||
Orbital myositis, Condition aggravated, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 66 | 26560229 |
US |
23 | 2 |
Rash erythematous, Pruritus, Burning sensation, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 67 | 26560323 |
US |
35 | 1 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, |
||||
DUPILUMAB, DUPILUMAB, SECUKINUMAB, |
||||
| 68 | 26560400 |
US |
55 | 2 |
Pain in extremity, Headache, Locomotive syndrome, Rest regimen, Arthralgia, Condition aggravated, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 69 | 26560411 |
US |
45 | 1 |
Nasopharyngitis, Nasal congestion, Condition aggravated, Rhinorrhoea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 70 | 26560531 |
US |
2 | |
Hidradenitis, Chronic spontaneous urticaria, Condition aggravated, Viral infection, Vomiting, |
||||
REMIBRUTINIB, |
||||
| 71 | 26560572 |
27 | ||
Limb operation, Hidradenitis, Condition aggravated, |
||||
BIMEKIZUMAB, |
||||
| 72 | 26560598 |
AU |
29 | 2 |
Colitis ulcerative, Condition aggravated, |
||||
MESALAMINE, MESALAMINE, VEDOLIZUMAB, AZATHIOPRINE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ISOTRETINOIN, INFLIXIMAB, SPIRONOLACTONE, |
||||
| 73 | 26560703 |
EU |
87 | 1 |
Contraindicated product prescribed, Hypernatraemia, Condition aggravated, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 74 | 26560842 |
US |
72 | 1 |
Ammonia increased, Hepatic cirrhosis, Condition aggravated, Hospitalisation, Confusional state, Therapy interrupted, Product use issue, |
||||
RIFAXIMIN, RIFAXIMIN, |
||||
| 75 | 26560865 |
34 | ||
Hidradenitis, Condition aggravated, Psoriasis, Product availability issue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 76 | 26560921 |
31 | ||
Hidradenitis, Condition aggravated, Discomfort, Excessive cerumen production, |
||||
BIMEKIZUMAB, |
||||
| 77 | 26561459 |
US |
73 | 2 |
Device malfunction, Product substitution issue, Condition aggravated, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 78 | 26561497 |
22 | ||
Hidradenitis, Condition aggravated, Stress, Psoriasis, |
||||
BIMEKIZUMAB, |
||||
| 79 | 26563868 |
2 | ||
Condition aggravated, Abdominal distension, Surgery, |
||||
DROXIDOPA, |
||||
| 80 | 26563869 |
1 | ||
Complement deficiency disease, Condition aggravated, |
||||
ICATIBANT ACETATE, |
||||
| 81 | 26570211 |
1 | ||
Infection, Rash, Quality of life decreased, Product use issue, Pulmonary vasculitis, Condition aggravated, |
||||
MEPOLIZUMAB, |
||||
| 82 | 26550029 |
US |
55 | 2 |
Joint swelling, Condition aggravated, Arthralgia, |
||||
SARILUMAB, |
||||
| 83 | 26550064 |
US |
71 | 1 |
Sinusitis, Condition aggravated, Chronic obstructive pulmonary disease, |
||||
DUPILUMAB, |
||||
| 84 | 26550088 |
US |
60 | 1 |
Joint swelling, Condition aggravated, Arthralgia, |
||||
SARILUMAB, |
||||
| 85 | 26550095 |
US |
13 | 2 |
Chest pain, Peripheral swelling, Condition aggravated, Musculoskeletal stiffness, Condition aggravated, Urticaria, Condition aggravated, Nausea, |
||||
DUPILUMAB, ATOMOXETINE, ATOMOXETINE, CLONIDINE, FOLIC ACID, ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, FAMOTIDINE, CARBO MORE, CIMETIDINE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, |
||||
| 86 | 26550246 |
US |
2 | |
Blister, Condition aggravated, Injection site pain, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FISH OIL, GARLIC, SUMATRIPTAN, LISINOPRIL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, PIMECROLIMUS, |
||||
| 87 | 26550315 |
US |
2 | |
Intestinal obstruction, Condition aggravated, |
||||
UPADACITINIB, |
||||
| 88 | 26550414 |
US |
1 | |
Product dose omission issue, Therapeutic product effect decreased, Condition aggravated, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 89 | 26550578 |
US |
||
Condition aggravated, Off label use, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 90 | 26550651 |
US |
2 | |
Hospitalisation, Condition aggravated, Knee arthroplasty, |
||||
ADALIMUMAB, ADALIMUMAB, |
||||
| 91 | 26550675 |
US |
2 | |
Hypertrophic cardiomyopathy, Injection site papule, Injection site pruritus, Nasopharyngitis, Bronchitis, Condition aggravated, Pharyngitis, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 92 | 26550737 |
US |
64 | 1 |
Panic attack, Condition aggravated, Depression, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 93 | 26550795 |
53 | ||
Hidradenitis, Condition aggravated, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 94 | 26550796 |
RU |
1 | |
Chronic spontaneous urticaria, Condition aggravated, Angioedema, Quality of life decreased, |
||||
OMALIZUMAB, OMALIZUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 95 | 26551132 |
US |
2 | |
Neuralgia, Condition aggravated, Nausea, Diarrhoea, Headache, Abdominal pain upper, Paraesthesia, Fatigue, Dizziness, Abnormal dreams, Nightmare, Brain fog, Tinnitus, |
||||
SERTRALINE HYDROCHLORIDE, |
||||
| 96 | 26551135 |
US |
2 | |
Osteoarthritis, Condition aggravated, |
||||
RISANKIZUMAB-RZAA, |
||||
| 97 | 26551156 |
US |
2 | |
Irritability, Aggression, Condition aggravated, Product substitution issue, |
||||
SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, |
||||
| 98 | 26551208 |
EU |
2 | |
Ovarian cancer, Condition aggravated, Drug ineffective, |
||||
BEVACIZUMAB, BEVACIZUMAB, PLATINUM, PLATINUM, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PANTOPRAZOLE, AMLODIPINE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 99 | 26551500 |
US |
||
Parkinson^s disease psychosis, Condition aggravated, |
||||
PIMAVANSERIN TARTRATE, MORPHINE, |
||||
| 100 | 26551580 |
EU |
88 | 2 |
Cardiac failure acute, Gastric cancer, Muscular weakness, Mobility decreased, Condition aggravated, Tachycardia, Fatigue, Nasopharyngitis, Vitamin B12 decreased, Chronic gastritis, Fluid intake reduced, Obsessive-compulsive disorder, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, DICLOFENAC, DICLOFENAC SODIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TECHNETIUM TC-99M, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28